BICLUSTER_ID : UPREG-34
PATHOGENS /2/ : streptococcus pneumoniae,yersinia enterocolitica
TARGETS /44/ : MMP13, MMP12, NDUFA3, NDUFB8, NDUFV1, NDUFA11, CYP1B1, SLC7A11, NDUFB5, NDUFS8, NDUFS1, NDUFA8, UQCRC1, NFKB1, NDUFS6, GSK3B, NDUFAB1, NDUFB2, HK1, IL1R1, NDUFC1, NDUFB10, NDUFA13, NDUFS5, NDUFV2, UAP1, SDHB, BCL2, SERPINB2, PIM1, NDUFA2, TXNRD1, UCK2, CDK6, NDUFB3, NDUFA9, NDUFS4, NR3C1, NP, NDUFA4, NDUFB6, IL6, PTGS2, PLAUR
Gene SetLeading Edge Genes
CORUM RESPIRATORY CHAIN COMPLEX I HOLOENZYME MITOCHONDRIALNDUFV2, NDUFS5, NDUFA13, NDUFA3, NDUFB8, NDUFV1, NDUFA11, NDUFB5, NDUFS8, NDUFS1, NDUFA2, NDUFA8, NDUFB3, NDUFA9, NDUFS6, NDUFS4, NDUFB6, NDUFA4, NDUFAB1, NDUFB2, NDUFB11, NDUFC1, NDUFB10
MOOTHA VOXPHOSNDUFA3, UQCR, NDUFB8, UQCRH, ATP5H, NDUFB5, NDUFS8, NDUFS1, NDUFA8, UQCRC1, ATP5O, NDUFS6, ATP5G1, ATP5J, ATP5E, NDUFAB1, COX7A2L, COX6C, NDUFB2, UQCRC2, ATP5F1, SURF1, NDUFC1, NDUFS5, SDHB, ATP5C1, COX5B, NDUFA2, NDUFB3, NDUFA9, NDUFS4, COX4I1, NDUFA4, NDUFB6, COX7C
NETPATH TGFBETA RECEPTOR PATHWAY UPDDX21, MMP13, PCNA, LIPG, MAP3K8, HBEGF, ETS1, CLCF1, CYP1B1, TSPAN13, SLC7A11, EXT1, PEG3, INHBA, ETV6, BHLHB2, CASP4, MAPK8, GTF2B, MAPK6, NFIL3, SPON2, PFKP, HK1, RYBP, IFRD1, JAG1, IL1R1, HIVEP2, GADD45B, SF1, UAP1, CDKN1A, SOX4, PIM1, FHL2, IER3, UCK2, CLU, CDK6, FOXD1, NP, ETS2, IL6, ATF3, PTGS2, SNF1LK, CDKN2B, MSC, PLAUR
NETPATH IL 1 PATHWAY UPNR4A3, MMP12, HBEGF, SERPINB2, RARS, MT2A, CXCL2, TXNRD1, PTX3, NFKB1, CXCL1, LIF, NP, IL6, PTGS2, ZFP36
NETPATH TNF ALPHA PATHWAY DOWNEXT1, CXCL2, BHLHB2, KLF6, REL, CXCL1, NR3C1, MAPK6, GSK3B, TIPARP, MAFF, GEM, IL6, TNFAIP3, PTGS2, ZFP36, IRF1
NCI ATF2 PATHWAYATF3, IL6, BCL2, CUL3, DUSP1
NETPATH IL 1 PATHWAYIL1RN, PELI1, IL1R1
NETPATH IL 6 PATHWAY UPCLU, GADD45B, CXCL1, CITED2, MAP3K8, MAFF, ZFP36, PIM1, IRF1, BHLHB2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
SNIJDERS AMPLIFIED IN HEAD AND NECK TUMORS
WEINMANN ADAPTATION TO HYPOXIA DN
MASSARWEH TAMOXIFEN RESISTANCE UP
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
CHUANG OXIDATIVE STRESS RESPONSE UP
VARELA ZMPSTE24 TARGETS UP
LI CISPLATIN RESISTANCE UP
ONDER CDH1 TARGETS 2 UP
LINDSTEDT DENDRITIC CELL MATURATION B
BRUECKNER TARGETS OF MIRLET7A3 DN
RASHI RESPONSE TO IONIZING RADIATION 2
HUANG FOXA2 TARGETS DN
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
SESTO RESPONSE TO UV C0
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
KIM WT1 TARGETS 12HR DN
NETPATH IL 7 PATHWAY UP
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS YELLOW DN
WANG SMARCE1 TARGETS UP
BILD CTNNB1 ONCOGENIC SIGNATURE
JEON SMAD6 TARGETS UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ZHU CMV 24 HR DN
BOYAULT LIVER CANCER SUBCLASS G56 DN
AGARWAL AKT PATHWAY TARGETS
HINATA NFKB TARGETS KERATINOCYTE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
AMIT SERUM RESPONSE 60 MCF10A
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
MCBRYAN PUBERTAL BREAST 3 4WK UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
CERVERA SDHB TARGETS 1 UP
NCI REG GR PATHWAY
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
KORKOLA TERATOMA
SENGUPTA NASOPHARYNGEAL CARCINOMA UP
FRASOR TAMOXIFEN RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
REACTOME ELECTRON TRANSPORT CHAIN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
GAJATE RESPONSE TO TRABECTEDIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
LEE LIVER CANCER E2F1 UP
HELLER SILENCED BY METHYLATION UP
GOZGIT ESR1 TARGETS DN
SUNG METASTASIS STROMA UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
SASSON RESPONSE TO GONADOTROPHINS DN
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
RUGO STRESS RESPONSE SUBSET F
GERY CEBP TARGETS
NCI P53DOWNSTREAMPATHWAY
SPIRA SMOKERS LUNG CANCER UP
CHASSOT SKIN WOUND
CERVERA SDHB TARGETS 2
TIAN TNF SIGNALING VIA NFKB
GENTILE UV LOW DOSE UP
HUANG DASATINIB RESISTANCE UP
PEREZ TP63 TARGETS
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
CREIGHTON ENDOCRINE THERAPY RESISTANCE 5
JI METASTASIS REPRESSED BY STK11
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL UP
KHETCHOUMIAN TRIM24 TARGETS UP
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
HENDRICKS SMARCA4 TARGETS UP
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
SCHAVOLT TARGETS OF TP53 AND TP63
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
SHEDDEN LUNG CANCER GOOD SURVIVAL A4
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
CHANG POU5F1 TARGETS UP
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA PPARA PATHWAY
ENK UV RESPONSE EPIDERMIS DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRASOR RESPONSE TO ESTRADIOL DN
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
SASSON RESPONSE TO FORSKOLIN DN
FERRARI RESPONSE TO FENRETINIDE UP
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
CREIGHTON ENDOCRINE THERAPY RESISTANCE 4
SIG CD40PATHWAYMAP
YAO HOXA10 TARGETS VIA PROGESTERONE DN
ELVIDGE HIF1A AND HIF2A TARGETS DN
MASSARWEH RESPONSE TO ESTRADIOL
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
NETPATH IL 5 PATHWAY UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
WANG RECURRENT LIVER CANCER DN
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ENGELMANN CANCER PROGENITORS UP
LEE RECENT THYMIC EMIGRANT
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
DACOSTA ERCC3 ALLELE XPCS VS TTD DN
WANG METHYLATED IN BREAST CANCER
BECKER TAMOXIFEN RESISTANCE DN
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
KIM WT1 TARGETS UP
SILIGAN BOUND BY EWS FLT1 FUSION
ONDER CDH1 TARGETS 1 DN
LINDSTEDT DENDRITIC CELL MATURATION C
SHAFFER IRF4 TARGETS IN ACTIVATED DENDRITIC CELL
WANG HCP PROSTATE CANCER
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
IIZUKA RECURRENT LIVER CANCER
NETPATH WNT PATHWAY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
REACTOME CRMPS IN SEMA3A SIGNALING
KIM WT1 TARGETS 8HR UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
LENAOUR DENDRITIC CELL MATURATION UP
MARCHINI TRABECTEDIN RESISTANCE DN
PEREZ TP53 AND TP63 TARGETS
TENEDINI MEGAKARYOCYTE MARKERS
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
MCBRYAN PUBERTAL BREAST 4 5WK UP
KYNG DNA DAMAGE BY 4NQO OR GAMMA RADIATION
LINDSTEDT DENDRITIC CELL MATURATION A
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS
XU RESPONSE TO TRETINOIN UP
BASAKI YBX1 TARGETS DN
ELVIDGE HYPOXIA UP
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
BROWNE INTERFERON RESPONSIVE GENES
FARMER BREAST CANCER BASAL VS LULMINAL
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
NUYTTEN NIPP1 TARGETS UP
GENTILE UV RESPONSE CLUSTER D1
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
SEMENZA HIF1 TARGETS
BIOCARTA ETS PATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
HOQUE METHYLATED IN CANCER
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13
NEWMAN ERCC6 TARGETS UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
GESERICK TERT TARGETS DN
NGUYEN NOTCH1 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
NCI IL1PATHWAY
SESTO RESPONSE TO UV C3
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GENTILE UV HIGH DOSE DN
NETPATH IL 2 PATHWAY
SENESE HDAC2 TARGETS UP
GRUETZMANN PANCREATIC CANCER UP
NCI HIF2PATHWAY
ROZANOV MMP14 TARGETS UP
OKUMURA INFLAMMATORY RESPONSE LPS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
VALK AML CLUSTER 2
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
KOMMAGANI TP63 GAMMA TARGETS
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NETPATH EGFR1 PATHWAY DOWN
LEONARD HYPOXIA
BONCI TARGETS OF MIR15A AND MIR16 1
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN
RODRIGUES THYROID CARCINOMA DN
DAZARD RESPONSE TO UV SCC UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
LIU PROSTATE CANCER DN
CHANDRAN METASTASIS DN
NETPATH IL 7 PATHWAY
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
MAHADEVAN RESPONSE TO MP470 DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KARAKAS TGFB1 SIGNALING
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
KAN RESPONSE TO ARSENIC TRIOXIDE
SWEET LUNG CANCER KRAS DN
TSAI DNAJB4 TARGETS DN
WEST ADRENOCORTICAL TUMOR MARKERS DN
SOUCEK MYC TARGETS
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 6
BILBAN B CLL LPL DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
FARMER BREAST CANCER CLUSTER 5
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
GOLDRATH ANTIGEN RESPONSE
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
RIGGI EWING SARCOMA PROGENITOR DN
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
PETRETTO CARDIAC HYPERTROPHY
BERENJENO TRANSFORMED BY RHOA FOREVER DN
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
AMUNDSON DNA DAMAGE RESPONSE TP53
DAZARD UV RESPONSE CLUSTER G2
LEE SP4 THYMOCYTE
AMIT SERUM RESPONSE 40 MCF10A
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
MASSARWEH TAMOXIFEN RESISTANCE DN
JAEGER METASTASIS DN
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
SANA TNF SIGNALING UP
SENESE HDAC1 AND HDAC2 TARGETS UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
ONDER CDH1 TARGETS 2 DN
AMIT EGF RESPONSE 240 HELA
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
JISON SICKLE CELL DISEASE UP
CORUM 55S RIBOSOME MITOCHONDRIAL
NCI NFKAPPABCANONICALPATHWAY
DASU IL6 SIGNALING UP
NETPATH IL 2 PATHWAY UP
HELLER HDAC TARGETS DN
HUPER BREAST BASAL VS LUMINAL UP
CROONQUIST NRAS VS STROMAL STIMULATION DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
TAKADA GASTRIC CANCER COPY NUMBER UP
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bl6yersinia enterocolitica p60 bcstreptococcus pneumoniae g54GeneSet Name
0.00000 0.00000 0.03328CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL
0.00000 0.00000 0.05316MOOTHA_VOXPHOS
0.05939 0.08744 0.03675NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.00000 0.00001 0.02186NETPATH_IL_1_PATHWAY_UP
0.00010 0.00000 0.00809NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.05363 0.00891 0.03036NCI_ATF2_PATHWAY
0.02533 0.00206 0.03624NETPATH_IL_1_PATHWAY
0.00000 0.00000 0.01842NETPATH_IL_6_PATHWAY_UP
0.00021 0.00000 0.03257GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00010 0.00009 0.08911MAHAJAN_RESPONSE_TO_IL1A_UP
0.18758 0.02934 0.06938SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.00006 0.00000 0.00875WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.09694 0.18277 0.00108MASSARWEH_TAMOXIFEN_RESISTANCE_UP
0.01562 0.00358 0.08248LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.03690 0.00738 0.00677VANHARANTA_UTERINE_FIBROID_DN
0.05687 0.11943 0.12323CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.15490 0.15192 0.01900VARELA_ZMPSTE24_TARGETS_UP
0.02839 0.01617 0.09240LI_CISPLATIN_RESISTANCE_UP
0.00306 0.01911 0.02667ONDER_CDH1_TARGETS_2_UP
0.04591 0.00237 0.00817LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00346 0.00671 0.00199BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00297 0.00008 0.00271RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.02841 0.13390 0.10801HUANG_FOXA2_TARGETS_DN
0.05650 0.05562 0.19106CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.00543 0.00171 0.04813LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.03636 0.02137 0.09379GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.11700 0.11863 0.00808SESTO_RESPONSE_TO_UV_C0
0.00563 0.00492 0.03272IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00021 0.00031 0.02615AMIT_EGF_RESPONSE_40_HELA
0.09354 0.03689 0.06314KIM_WT1_TARGETS_12HR_DN
0.00709 0.00028 0.11486NETPATH_IL_7_PATHWAY_UP
0.10787 0.01370 0.17226MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.15491 0.16745 0.06570GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.00803 0.02535 0.00621WANG_SMARCE1_TARGETS_UP
0.15341 0.11727 0.01439BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.01900 0.03022 0.02288JEON_SMAD6_TARGETS_UP
0.00184 0.00000 0.09013THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00708 0.00004 0.13995TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.05165 0.14659 0.19723ZHU_CMV_24_HR_DN
0.12093 0.14873 0.12091BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.07827 0.14750 0.18895AGARWAL_AKT_PATHWAY_TARGETS
0.00000 0.00000 0.00568HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.17439 0.11062 0.02436KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.01647 0.00004 0.10730MARKEY_RB1_ACUTE_LOF_UP
0.00000 0.00000 0.00321AMIT_SERUM_RESPONSE_60_MCF10A
0.10560 0.01191 0.00558GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.05253 0.00263 0.04828HAN_SATB1_TARGETS_DN
0.03654 0.02172 0.10702TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.02287 0.06346 0.04431MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.02147 0.03733 0.00390RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.15332 0.08095 0.06013CERVERA_SDHB_TARGETS_1_UP
0.05415 0.03179 0.05556NCI_REG_GR_PATHWAY
0.06190 0.01313 0.09373TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.02158 0.17927 0.07871KORKOLA_TERATOMA
0.02490 0.01756 0.08507SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.09874 0.11073 0.08537FRASOR_TAMOXIFEN_RESPONSE_UP
0.00032 0.00020 0.01216GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00029 0.00004 0.01466AMIT_EGF_RESPONSE_120_HELA
0.07528 0.01255 0.11238BIOCARTA_RANKL_PATHWAY
0.06859 0.04558 0.07999DANG_REGULATED_BY_MYC_DN
0.00000 0.00000 0.02389REACTOME_ELECTRON_TRANSPORT_CHAIN
0.07195 0.06188 0.00715FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.02695 0.00443 0.00696GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00305 0.00857 0.03041SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00000 0.00001 0.00016PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00563 0.00219 0.05639LEE_LIVER_CANCER_E2F1_UP
0.00251 0.00028 0.17361HELLER_SILENCED_BY_METHYLATION_UP
0.00424 0.00135 0.03000GOZGIT_ESR1_TARGETS_DN
0.02692 0.12816 0.00325SUNG_METASTASIS_STROMA_UP
0.06583 0.05580 0.14788NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.14981 0.16479 0.05316VANTVEER_BREAST_CANCER_ESR1_DN
0.06899 0.02319 0.10101SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.00000 0.00000 0.12533VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04624 0.00068 0.09635BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.02449 0.04809 0.15933RUGO_STRESS_RESPONSE_SUBSET_F
0.00040 0.00510 0.12493GERY_CEBP_TARGETS
0.11365 0.13034 0.06541NCI_P53DOWNSTREAMPATHWAY
0.04515 0.19773 0.02072SPIRA_SMOKERS_LUNG_CANCER_UP
0.07095 0.00892 0.03610CHASSOT_SKIN_WOUND
0.04570 0.02065 0.04917CERVERA_SDHB_TARGETS_2
0.00016 0.00000 0.16057TIAN_TNF_SIGNALING_VIA_NFKB
0.00394 0.01341 0.16976GENTILE_UV_LOW_DOSE_UP
0.00029 0.00000 0.00242HUANG_DASATINIB_RESISTANCE_UP
0.05482 0.01504 0.12701PEREZ_TP63_TARGETS
0.00005 0.00004 0.06179CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00034 0.00008 0.02432HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00176 0.00028 0.00034CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00038 0.00145 0.00810MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.14976 0.10732 0.00074CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
0.01585 0.02414 0.07163JI_METASTASIS_REPRESSED_BY_STK11
0.01204 0.11765 0.00828SESTO_RESPONSE_TO_UV_C1
0.00954 0.01017 0.09861CROONQUIST_STROMAL_STIMULATION_UP
0.01657 0.00008 0.14745CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.12910 0.11761 0.00269CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP
0.05355 0.01394 0.02156KHETCHOUMIAN_TRIM24_TARGETS_UP
0.01137 0.00038 0.00695HORIUCHI_WTAP_TARGETS_UP
0.00424 0.00000 0.02446WOO_LIVER_CANCER_RECURRENCE_UP
0.13271 0.04786 0.03089RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00504 0.01065 0.02167CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.12825 0.01530 0.00923DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.00464 0.11506 0.07872HENDRICKS_SMARCA4_TARGETS_UP
0.00924 0.03924 0.03087CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.01467 0.02618 0.01840TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.04121 0.06365 0.16976SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.04762 0.00056 0.11870DER_IFN_BETA_RESPONSE_UP
0.02538 0.00299 0.01803DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00164 0.00313 0.06964DIRMEIER_LMP1_RESPONSE_LATE_UP
0.13202 0.03210 0.04888SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.00018 0.00003 0.03498BASSO_CD40_SIGNALING_UP
0.00683 0.00078 0.00388TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.13956 0.06566 0.16490CHANG_POU5F1_TARGETS_UP
0.00000 0.00000 0.00022NAGASHIMA_NRG1_SIGNALING_UP
0.00021 0.00008 0.16651MARZEC_IL2_SIGNALING_UP
0.02843 0.04178 0.18979BIOCARTA_PPARA_PATHWAY
0.10880 0.04266 0.00387ENK_UV_RESPONSE_EPIDERMIS_DN
0.05840 0.12784 0.09092ZERBINI_RESPONSE_TO_SULINDAC_UP
0.03028 0.06088 0.10110WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.02087 0.02899 0.00187FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.00030 0.00013 0.02045CROMER_TUMORIGENESIS_UP
0.17993 0.13847 0.03706FRIDMAN_SENESCENCE_UP
0.15992 0.03231 0.16936SASSON_RESPONSE_TO_FORSKOLIN_DN
0.01472 0.00050 0.01205FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.01462 0.00000 0.15101SANA_RESPONSE_TO_IFNG_UP
0.00000 0.00005 0.02602ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.09489 0.13001 0.02400CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.18839 0.19065 0.02635SIG_CD40PATHWAYMAP
0.14420 0.04771 0.15985YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.04573 0.19435 0.00054ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00872 0.00515 0.09848MASSARWEH_RESPONSE_TO_ESTRADIOL
0.00917 0.00739 0.07559WU_HBX_TARGETS_1_UP
0.00807 0.00074 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.00711 0.00159 0.07746NETPATH_IL_5_PATHWAY_UP
0.05513 0.09688 0.04298RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.10907 0.02120 0.05148WANG_RECURRENT_LIVER_CANCER_DN
0.11142 0.09830 0.08290SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.00000 0.00000 0.02093SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00038 0.00205 0.11210NETPATH_EGFR1_PATHWAY_UP
0.00398 0.00030 0.11160GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00489 0.00226 0.01005CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.10778 0.13315 0.00380ENGELMANN_CANCER_PROGENITORS_UP
0.03654 0.09721 0.09093LEE_RECENT_THYMIC_EMIGRANT
0.12076 0.02118 0.16966MURAKAMI_UV_RESPONSE_6HR_UP
0.02031 0.01041 0.00031BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.01012 0.00242 0.06987DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.00162 0.00032 0.02474WANG_METHYLATED_IN_BREAST_CANCER
0.15490 0.09456 0.08412BECKER_TAMOXIFEN_RESISTANCE_DN
0.01901 0.00109 0.05349SENESE_HDAC1_TARGETS_UP
0.04786 0.08106 0.15815LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00039 0.00000 0.00273KIM_WT1_TARGETS_UP
0.02917 0.11094 0.12820SILIGAN_BOUND_BY_EWS_FLT1_FUSION
0.00405 0.01007 0.07758ONDER_CDH1_TARGETS_1_DN
0.04457 0.07459 0.00761LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.13349 0.17380 0.04452SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.15836 0.04785 0.04217WANG_HCP_PROSTATE_CANCER
0.00006 0.00004 0.13868HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00028 0.00017 0.00018ELVIDGE_HYPOXIA_BY_DMOG_UP
0.09789 0.03196 0.08004IIZUKA_RECURRENT_LIVER_CANCER
0.09285 0.15536 0.14364NETPATH_WNT_PATHWAY_UP
0.00000 0.00000 0.01851OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.01126 0.01317 0.10586BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.04754 0.05386 0.00850RUTELLA_RESPONSE_TO_HGF_UP
0.02844 0.00119 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00952 0.08587 0.00965REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.06776 0.01140 0.01014KIM_WT1_TARGETS_8HR_UP
0.00000 0.00000 0.00267PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.10495 0.14639 0.00071ELVIDGE_HIF1A_TARGETS_DN
0.01771 0.01015 0.04065LI_CISPLATIN_RESISTANCE_DN
0.01129 0.05114 0.09690LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.00513 0.00361 0.19310MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.17948 0.04676 0.06602PEREZ_TP53_AND_TP63_TARGETS
0.04211 0.02423 0.11247TENEDINI_MEGAKARYOCYTE_MARKERS
0.00019 0.00041 0.01145CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.06852 0.10276 0.09151HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.06739 0.01369 0.03294MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.03739 0.05746 0.16739KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.00029 0.00000 0.16372LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.14876 0.00249 0.03706REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.14753 0.07466 0.13874XU_RESPONSE_TO_TRETINOIN_UP
0.16659 0.07658 0.00152BASAKI_YBX1_TARGETS_DN
0.00031 0.00036 0.00034ELVIDGE_HYPOXIA_UP
0.04032 0.07132 0.09386MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.00006 0.00000 0.11107BROWNE_INTERFERON_RESPONSIVE_GENES
0.18863 0.14786 0.01665FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.01867 0.00729 0.14828TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.14988 0.11392 0.00315NUYTTEN_NIPP1_TARGETS_UP
0.00201 0.00669 0.19995GENTILE_UV_RESPONSE_CLUSTER_D1
0.00058 0.00008 0.17463KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01826 0.02457 0.18837XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.08169 0.06140 0.03295OSADA_ASCL1_TARGETS_DN
0.00356 0.00032 0.00276NUYTTEN_EZH2_TARGETS_UP
0.00201 0.00013 0.05455DUTTA_APOPTOSIS_VIA_NFKB
0.05105 0.08331 0.05377DELYS_THYROID_CANCER_UP
0.00018 0.00000 0.08905DIRMEIER_LMP1_RESPONSE_EARLY
0.00609 0.02874 0.17257SEMENZA_HIF1_TARGETS
0.01583 0.16753 0.12208BIOCARTA_ETS_PATHWAY
0.00000 0.00000 0.11282ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00026 0.00099 0.03102ONDER_CDH1_TARGETS_3_DN
0.06839 0.05249 0.01828RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.02280 0.00048 0.16628HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.10917 0.00659 0.13119NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.01519 0.00442 0.01549WINTER_HYPOXIA_METAGENE
0.03708 0.00076 0.11203HOQUE_METHYLATED_IN_CANCER
0.00000 0.00000 0.01884YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
0.03258 0.03715 0.04821NEWMAN_ERCC6_TARGETS_UP
0.00056 0.00001 0.01570GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.06979 0.02930 0.04868TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.01680FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.03776 0.01384 0.09361PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.00980 0.11465 0.02405SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.17984 0.14780 0.07319NETPATH_TNF_ALPHA_PATHWAY_UP
0.00000 0.00004 0.00310GESERICK_TERT_TARGETS_DN
0.05226 0.12402 0.01647NGUYEN_NOTCH1_TARGETS_DN
0.00007 0.00000 0.00320AMIT_SERUM_RESPONSE_120_MCF10A
0.00222 0.00673 0.04469BROWNE_HCMV_INFECTION_2HR_UP
0.04794 0.01166 0.18632NCI_IL1PATHWAY
0.00078 0.00270 0.01104SESTO_RESPONSE_TO_UV_C3
0.14037 0.08441 0.05027WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.00109 0.00000 0.03258GEISS_RESPONSE_TO_DSRNA_UP
0.00272 0.00007 0.03598GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.08547 0.06793 0.00382GENTILE_UV_HIGH_DOSE_DN
0.10305 0.09647 0.04610NETPATH_IL_2_PATHWAY
0.13212 0.02576 0.12202SENESE_HDAC2_TARGETS_UP
0.11422 0.15514 0.00920GRUETZMANN_PANCREATIC_CANCER_UP
0.01458 0.01064 0.06914NCI_HIF2PATHWAY
0.05243 0.12290 0.08267ROZANOV_MMP14_TARGETS_UP
0.00621 0.00041 0.04102OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.00058 0.00168 0.06587LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.00045NAGASHIMA_EGF_SIGNALING_UP
0.06744 0.04380 0.01300AMIT_DELAYED_EARLY_GENES
0.02994 0.00675 0.11461VALK_AML_CLUSTER_2
0.01090 0.01120 0.04467KRIGE_AMINO_ACID_DEPRIVATION
0.00000 0.00000 0.00090AMIT_EGF_RESPONSE_60_MCF10A
0.11613 0.08720 0.18882KOMMAGANI_TP63_GAMMA_TARGETS
0.00037 0.00304 0.17017NOJIMA_SFRP2_TARGETS_UP
0.01499 0.02172 0.01846CHEN_HOXA5_TARGETS_6HR_UP
0.02220 0.00508 0.01189SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00000 0.01878OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.10574 0.10486 0.04385NETPATH_EGFR1_PATHWAY_DOWN
0.01346 0.02593 0.00548LEONARD_HYPOXIA
0.00933 0.00146 0.02165BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.03894 0.02539 0.04752RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.00115 0.00112 0.02448RODRIGUES_THYROID_CARCINOMA_DN
0.16634 0.13016 0.01405DAZARD_RESPONSE_TO_UV_SCC_UP
0.00022 0.00037 0.02527HALMOS_CEBPA_TARGETS_UP
0.00037 0.00041 0.00050WU_CELL_MIGRATION
0.00473 0.04729 0.02510LIU_PROSTATE_CANCER_DN
0.12846 0.13971 0.15824CHANDRAN_METASTASIS_DN
0.17603 0.03245 0.15208NETPATH_IL_7_PATHWAY
0.03049 0.01063 0.01436ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.03385 0.02619 0.04993GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.07122 0.09717 0.09090ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.12402 0.00032 0.10748REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.00072 0.00009 0.15502MAHADEVAN_RESPONSE_TO_MP470_DN
0.00000 0.00000 0.08161TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00029 0.00029 0.10031HARRIS_HYPOXIA
0.02263 0.00008 0.12500FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.03294 0.11345 0.01745KARAKAS_TGFB1_SIGNALING
0.02559 0.02444 0.04079CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00165 0.00121 0.04440KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.06073 0.17598 0.16976SWEET_LUNG_CANCER_KRAS_DN
0.05249 0.03816 0.02436TSAI_DNAJB4_TARGETS_DN
0.04550 0.01878 0.08316WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN
0.00018 0.00008 0.08229SOUCEK_MYC_TARGETS
0.06778 0.18663 0.11163YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.00270 0.00101 0.05066BILBAN_B_CLL_LPL_DN
0.06984 0.06249 0.04689IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.05171 0.06073 0.03107FARMER_BREAST_CANCER_CLUSTER_5
0.00320 0.01983 0.17440GENTILE_UV_LOW_DOSE_DN
0.02608 0.00021 0.08960ZHAN_MULTIPLE_MYELOMA_LB_DN
0.19042 0.17956 0.18885GOLDRATH_ANTIGEN_RESPONSE
0.00394 0.00353 0.09034SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00000 0.00000 0.00093BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000 0.01216LIANG_SILENCED_BY_METHYLATION_2
0.06189 0.02597 0.03237DAUER_STAT3_TARGETS_UP
0.03905 0.00264 0.06354RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.14030 0.00389 0.11860DER_IFN_ALPHA_RESPONSE_UP
0.17416 0.06772 0.00004MENSE_HYPOXIA_UP
0.03249 0.07438 0.19020PETRETTO_CARDIAC_HYPERTROPHY
0.00332 0.00060 0.02282BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.08832 0.06783 0.09462ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00019 0.00028 0.02905AMIT_EGF_RESPONSE_60_HELA
0.13590 0.16353 0.07960AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.01250 0.01385 0.03619DAZARD_UV_RESPONSE_CLUSTER_G2
0.05402 0.12851 0.15653LEE_SP4_THYMOCYTE
0.00000 0.00004 0.00737AMIT_SERUM_RESPONSE_40_MCF10A
0.00993 0.01760 0.07822HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.06854 0.01341 0.05295MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.03406 0.10797 0.01316JAEGER_METASTASIS_DN
0.00000 0.00000 0.00231ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.02310 0.01398 0.18318HELLER_SILENCED_BY_METHYLATION_DN
0.05248 0.02071 0.05057BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00022 0.00000 0.15203SANA_TNF_SIGNALING_UP
0.01129 0.00026 0.15156SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00804 0.00023 0.13731SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00022 0.00011 0.00297ONDER_CDH1_TARGETS_2_DN
0.00964 0.00048 0.08012AMIT_EGF_RESPONSE_240_HELA
0.00019 0.00041 0.11522CASTELLANO_NRAS_TARGETS_UP
0.00030 0.00006 0.00067HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.06418 0.09043 0.00081UDAYAKUMAR_MED1_TARGETS_DN
0.00979 0.00039 0.03264SENESE_HDAC3_TARGETS_UP
0.00423 0.00917 0.00112CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00000 0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.06359 0.00209 0.04179JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.00000 0.06665CORUM_55S_RIBOSOME_MITOCHONDRIAL
0.04764 0.04547 0.05639NCI_NFKAPPABCANONICALPATHWAY
0.00177 0.00020 0.09369DASU_IL6_SIGNALING_UP
0.00994 0.00018 0.16635NETPATH_IL_2_PATHWAY_UP
0.04603 0.13193 0.17928HELLER_HDAC_TARGETS_DN
0.00812 0.00030 0.03108HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.04783 0.13492 0.17834CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00037 0.00000 0.03864GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05135 0.06165 0.05144TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP
0.04370 0.05022 0.01824ZUCCHI_METASTASIS_DN
0.04236 0.00209 0.00087BRUECKNER_TARGETS_OF_MIRLET7A3_UP